Herman G. M. Westenberg, Ph.D.

Original Research

Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients

June 2, 2009

Nienke C. C. Vulink, Damiaan Denys, Sjoerd B. A. H. A. Fluitman, et al

Original Research

Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial

May 15, 2007

Damiaan Denys, Filip Van Nieuwerburgh, Dieter Deforce, et al

Original Research

Behavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment

September 15, 2005

Nienke H. Tenneij, Harold J. G. M. van Megen, Damiaan A. J. P. Denys, et al

Letter to the Editor

Efficacy of Quetiapine in Generalized Social Anxiety Disorder: Results From an Open-Label Study

April 15, 2005

Sara I. J. Schutters, Harold J. G. M. van Megen, Herman G. M. Westenberg

Original Research

Bupropion for Patients With Obsessive-Compulsive Disorder: An Open-Label, Fixed-Dose Study

February 15, 2005

Nienke C. C. Vulink, Damiaan Denys, Herman G. M. Westenberg

Article

Overview of Panic and Social Anxiety Disorders

December 15, 2004

Herman G. M. Westenberg, Michael R. Liebowitz

Article

The Role of Dopamine in Obsessive-Compulsive Disorder: Preclinical and Clinical Evidence

December 15, 2004

Damiaan Denys, Joseph Zohar, Herman G. M. Westenberg

Original Research

A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors

August 16, 2004

Damiaan Denys, Femke de Geus, Harold J. G. M. van Megen, et al

Original Research

A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder

January 1, 2004

Damiaan Denys, Harold J. G. M. van Megen, Nic van der Wee, et al

Article

Social Anxiety Disorder and Generalized Anxiety Disorder: Serotonergic and Dopaminergic Neurocircuitry

June 1, 2002

Dan J. Stein, Herman G. M. Westenberg, Michael R. Liebowitz

Article

Pharmacology of Antidepressants: Selectivity or Multiplicity?

June 1, 1999

Herman G. M. Westenberg

Article

Consensus Statement on Social Anxiety Disorder From the International Consensus Group on Depression and Anxiety

May 21, 1998

James C. Ballenger, Jonathan R. T. Davidson, Yves Lecrubier, et al

Herman G. M. Westenberg, Ph.D.

Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients

Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial

Behavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment

Efficacy of Quetiapine in Generalized Social Anxiety Disorder: Results From an Open-Label Study

Bupropion for Patients With Obsessive-Compulsive Disorder: An Open-Label, Fixed-Dose Study

Overview of Panic and Social Anxiety Disorders

The Role of Dopamine in Obsessive-Compulsive Disorder: Preclinical and Clinical Evidence

A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors

A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder

Social Anxiety Disorder and Generalized Anxiety Disorder: Serotonergic and Dopaminergic Neurocircuitry

Pharmacology of Antidepressants: Selectivity or Multiplicity?

Consensus Statement on Social Anxiety Disorder From the International Consensus Group on Depression and Anxiety

ELSEWHERE:

FOLLOW US:

Herman G. M. Westenberg, Ph.D.

Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients

Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial

Behavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment

Efficacy of Quetiapine in Generalized Social Anxiety Disorder: Results From an Open-Label Study

Bupropion for Patients With Obsessive-Compulsive Disorder: An Open-Label, Fixed-Dose Study

Overview of Panic and Social Anxiety Disorders

The Role of Dopamine in Obsessive-Compulsive Disorder: Preclinical and Clinical Evidence

A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors

A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder

Social Anxiety Disorder and Generalized Anxiety Disorder: Serotonergic and Dopaminergic Neurocircuitry

Pharmacology of Antidepressants: Selectivity or Multiplicity?

Consensus Statement on Social Anxiety Disorder From the International Consensus Group on Depression and Anxiety

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles